MLLCF

$3.80+$0.20 (+5.56%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$2.25 – $4.15

82% from low

Exchange

OTC Link

Change$-13.25

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$11M	+515.0%	$-1.42	$-1.42–$-1.42	—	1
2027	$60M	+459.1%	$-1.29	$-1.29–$-1.29	—	1
2028	$1M	-97.9%	$-1.49	$-1.49–$-1.49	—	1
2029	$33M	+2510.4%	$-1.44	$-1.44–$-1.44	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 3 of the last 7 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-05-12	$-0.43	$-0.44	-2.9%
2026-03-12	$-0.39	$-0.43	-9.7%
2025-10-30	$-0.46	$-0.40	+14.4%
2025-08-25	$-0.49	$-0.55	-11.0%
2025-05-15	$-0.41	$-0.51	-25.0%
2025-03-06	$-0.43	$-0.37	+13.2%
2024-11-01	$-0.64	$-0.58	+9.6%

Intrinsic value

$2.97

Price

$3.80

Implied downside

-22%

Symbol	Price	Today	Mkt cap	P/E
MLLCFMolecular Partners AG	$3.80	+0.00%	$143M	—
AAWHAscend Wellness Holdings, Inc.	$0.41	-5.49%	$83M	—
BRIBFBrii Biosciences Limited	$0.13	+0.00%	$94M	—
BXPHFBotanix Pharmaceuticals Limited	$0.02	-19.64%	$62M	—
HOFBFHofseth BioCare ASA	$0.17

No one on the platform currently holds MLLCF.

Institutions holding (13F)

No tracked institution reports a position in MLLCF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

No one on the platform has traded MLLCF yet.

Stocktwits Earnings@StocktwitsEarningsMar 12
$MLLCF Q4 '25 Earnings Results & Recap For the full year 2026, Molecular Partners expects total operating expenses of CHF45M at constant exchange rates, including approximately CHF6M in non-cash effective costs.
View on StockTwits ↗
MarketBeat Earnings@EarningsInsiderJan 18
Molecular Partners Sees Short Interest Decrease from 113,400 shares to 71,200 shares. $MLLCF https://www.marketbeat.com/stocks/OTCMKTS/MLLC
View on StockTwits ↗
MarketBeat Earnings@EarningsInsiderJan 17
Molecular Partners Sees Short Interest Decrease from 113,400 shares to 71,200 shares. $MLLCF https://www.marketbeat.com/stocks/OTCMKTS/MLLC
View on StockTwits ↗
MarketBeat.com@MarketBeatJul 21
Molecular Partners's PT cut by Credit Suisse Group AG to CHF 6. https://www.marketbeat.com/r/1794611 $MLLCF
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.